Thyroid hormone withdrawal

OTHER2 trials

Sponsors

Genzyme, a Sanofi Company, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Conditions

Thyroid Cancer

Phase 2

The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer

RecruitingNCT03841617

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Thyroid Cancer

Start: 2019-07-29End: 2035-11-01Target: 30Updated: 2026-09-09

Unknown Phase

A Retrospective Observational Study Comparing Two Different Treatment Options in Thyroid Cancer Patients With T4 Tumours

CompletedNCT01736163

Genzyme, a Sanofi CompanyThyroid Cancer

Start: 2012-05-31End: 2012-08-31Updated: 2015-03-23